Search - tctmd.com

Displaying 81 - 100 of 217

Sort: Relevancy | Date

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

Presentation TCT 2016

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presentation TCT 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2016

February 28, 2016

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

February 14, 2016

News Daily News

肾脏去神经支配试验在很大程度上会受到意外偏倚的影响

January 19, 2016

News Daily News

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

January 19, 2016

News Daily News

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

January 19, 2016

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presentation TCT 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane

October 11, 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presentation TCT 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presenter: Ajay J. Kirtane, Felix Mahfoud, Darrel P. Francis

October 11, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Presentation CADECI 2015

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Presenter: Dr. Juan Gaspar

February 19, 2015

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

January 12, 2015

News Daily News

Repaso del Año: Los Médicos Señalan las Noticias Más Importantes en Cardiología Intervencionista de 2014

January 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.